Dom & Dawn’s Opinion on the CRO Industry? Click here to view the entire series.

Do You Feel that Many Bioanalytical CROs are Quick to Cover All of These Technologies? Click here to view the entire series.

What are Some Scenarios Where More Than One Approach is Needed? Click here to view the entire series.

Do You Have Examples of When You Started with One Testing Platform and Switched to Another? Click here to view the entire series.

How do You Know Which Approach is Best? Click here to view the entire series.

Are the Sensitivities Similar? Click here to view the entire series.

What are the Differences Between Time and Costs for Development? Click here to view the entire series.

Is Hybrid LC-MS/MS emerging as an Equal Partner? Click here to view the entire series.

What is Hybrid LC-MS/MS? Click here to view the entire series.

Are there any specific technologies that are more useful to have together? Click here to view the entire series.

What Makes a Good CRO for Bioanalysis? Click here to view the entire series.

Dawn Dufield, Ph.D. and Dominic Warrino, Ph.D. discuss their approach to ligand binding assays (LBAs) and hybrid mass spectrometry (Hybrid LC-MS/MS) in this 11-part video series. What Makes a Good CRO for Bioanalysis? Are there any specific technologies that are more useful to have together? What is a…